The Department of Health and Human Services will create a Foundry for American Biotechnology to produce technological solutions to address health security threats and enhance daily medical care, the agency announced today. The foundry will be located in Manchester, N.H., and managed in conjunction with the Advanced Regenerative Manufacturing Institute led by DEKA Research Corp., as part of a public-private partnership with HHS’ Office of the Assistant Secretary for Preparedness and Response. Its first project, a partnership with the Defense Advanced Research Projects Agency, will focus on maturing and validating small, automated devices that could go to disaster locations to make necessary medicines on site.

Related News Articles

Headline
Microsoft has released a security update to address a critical remote code execution vulnerability impacting multiple versions of Windows Server Update…
Headline
In part two of a recent blog, AHA National Advisor for Cybersecurity and Risk John Riggi and AHA Deputy National Advisor for Cybersecurity and Risk Scott Gee…
AHA Cyber Intel
In part one of this blog, we reviewed the number of cyberattacks the health care field endured this year compared to last; provided an overview of the lessons…
Headline
The National Emerging Special Pathogens Training and Education Center announced Oct. 15 that it will award $37.5 million in grants to 75 hospitals seeking to…
Headline
The Cybersecurity and Infrastructure Security Agency Oct. 15 released an emergency directive advising federal agencies to take stock of their F5 BIG-IP…
Headline
In part one of a new blog, John Riggi, AHA national advisor for cybersecurity and risk, and Scott Gee, AHA deputy national advisor for cybersecurity and risk,…